Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
29 August 2022 |
Main ID: |
NCT03243019 |
Date of registration:
|
01/08/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations
RAPAMALYMPH |
Scientific title:
|
Evaluation of the Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations of Poor Prognosis |
Date of first enrolment:
|
June 25, 2018 |
Target sample size:
|
28 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03243019 |
Study type:
|
Interventional |
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
Phase 2
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Pierre Fayoux, MD |
Address:
|
|
Telephone:
|
3 20 44 50 67 |
Email:
|
pierre.fayoux@chru-lille.fr |
Affiliation:
|
|
|
Name:
|
Pierre Fayoux, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University Hospital, Lille |
| |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|